Final FDA Guidance Issued on Evaluation and Labeling of Abuse-deterrent Opioids

The U.S. Food and Drug Administration today issued a final guidance to assist industry in developing opioid drug products with potentially abuse-deterrent properties.O

Source:: FDA News

Leave a Reply

Your email address will not be published. Required fields are marked *